Zimmer Biomet Holdings ZBH
NYSE ZBH
$99.81 -0.93 (-0.93%)
At close: Aug 20, 2026 · 2:34 PM UTC

Zimmer Biomet Holdings (ZBH) Liabilities from Discontinued Operations (2021)

Zimmer Biomet Holdings (ZBH) posted quarterly Liabilities from Discontinued Operations of 168400000.0 for Q4 2021.

Zimmer Biomet Holdings (ZBH) Liabilities from Discontinued Operations (2021) Analysis & Trends

Zimmer Biomet Holdings' Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 168400000.0 for Q4 2021.

  • In Q4 2021, Liabilities from Discontinued Operations changed N/A year-over-year to 168400000.0; the TTM figure through Dec 2021 stood at 168400000.0 (changed N/A YoY), while the FY2021 annual figure was 168400000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations for Q4 2021 stood at 168400000.0.
  • The five-year high for Liabilities from Discontinued Operations was 168400000.0 in Q4 2021, with the low at 168400000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn
10 Zimmer Biomet Holdings 19.18 Bn 18.77 Bn 1.54 Bn

Historic Data

Download Data
DateValue
Dec 31, 2021 168.40 Mn
Dec 31, 2021 168.40 Mn